Patients with cancer undergoing individually tailored exercise intervention also reported less mental fatigue.

Increased vulnerability seen for adults older than 65 years, individuals with cardiac cause, those with nonshockable rhythm.

The median overall survival was 38.21 months with radium-223 plus enzalutamide and 32.62 months with enzalutamide alone. For patients with metastatic castration-resistant prostate cancer (mCRPC) with ...

The median OS was 28 months with abiraterone-prednisone, 37 months with olaparib alone, and 68 months with abiraterone-prednisone-olaparib. In patients with metastatic castration-resistant prostate ...

Source: Getty Images Drs Uzzo, Chung, and Croll of Fox Chase Cancer Center at Temple University Health discuss top presentations from the ASCO Genitourinary Cancers Symposium 2026. The American ...

Investigators assessed shear wave elastography (SWE) in detecting subclinical renal damage in patients with LN currently in clinical remission.

Policy implementation linked to increase of 5.3 transplants per 1,000 listings in interrupted time series analysis. (HealthDay News) — Implementation of an Organ Procurement and Transplantation ...

More patients receiving obinutuzumab versus placebo had primary end point of SLE Responder Index 4. (HealthDay News) — For patients with systemic lupus erythematosus (SLE), obinutuzumab, a ...

In this retrospective study, researchers sought to determine the efficacy, safety, and effectiveness of a reduced ARSI dose compared to a full dose in non-metastatic castration-resistant prostate ...

The FDA grants Fast Track designation to nipocalimab for systemic lupus erythematosus following positive results from the phase 2b JASMINE trial.

(HealthDay News) — Poor childhood oral health is associated with an increased risk for atherosclerotic cardiovascular disease (ASCVD) in adulthood, according to a study published in the April 1 issue ...

Increase from 0.16 to 0.44 new monthly dispensations per 1,000 people reported between January 2016 and June 2024. (HealthDay News) — During the COVID-19 pandemic, rates of new stimulant prescriptions ...